 | • レポートコード：MRC2-11QY01413 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はHPVワクチンのグローバル市場について調査・分析したレポートです。種類別（青年、成人）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別HPVワクチンの競争状況、市場シェア ・世界のHPVワクチン市場：種類別市場規模 2015年-2020年（青年、成人） ・世界のHPVワクチン市場：種類別市場規模予測 2021年-2026年（青年、成人） ・世界のHPVワクチン市場：用途別市場規模 2015年-2020年（男性、女性） ・世界のHPVワクチン市場：用途別市場規模予測 2021年-2026年（男性、女性） ・北米のHPVワクチン市場分析：米国、カナダ ・ヨーロッパのHPVワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのHPVワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のHPVワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのHPVワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma、CSL、Emergent BioSolutions、GlaxoSmithKline、Johnson & Johnson、MedImmune、Merck、Pfizer、Sanofi Pasteur、Serum Institute ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.
HPV vaccine is an inactivated (not live) vaccine which protects against four major types of HPV. These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Human papillomaviruses (HPVs) are a group of more than 200 related viruses. More than 40 HPV types can be easily spread through direct sexual contact, from the skin and mucous membranes of infected people to the skin and mucous membranes of their partners. They can be spread by vaginal, anal, and oral sex (1). Other HPV types are responsible for non-genital warts, which are not sexually transmitted. The segment of Female HPV vaccine market witnessed growth at a noteworthy rate over the past few years and is expected to grow in the forecast period on the back of rising awareness regarding HPV related fatal diseases, rising healthcare expenditures along with rising disposable incomes. North America and Europe accounts for the maximum market share of the global HPV vaccines market and is expected to grow at highest CAGR during the forecast period.
Market Analysis and Insights: Global HPV Vaccines Market
The global HPV Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global HPV Vaccines Scope and Market Size
HPV Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HPV Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the HPV Vaccines market is segmented into
Adolescents
Adults
Segment by Application, the HPV Vaccines market is segmented into
Male
Female
Regional and Country-level Analysis
The HPV Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the HPV Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and HPV Vaccines Market Share Analysis
HPV Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in HPV Vaccines business, the date to enter into the HPV Vaccines market, HPV Vaccines product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
1 Study Coverage
1.1 HPV Vaccines Product Introduction
1.2 Market Segments
1.3 Key HPV Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global HPV Vaccines Market Size Growth Rate by Type
1.4.2 Adolescents
1.4.3 Adults
1.5 Market by Application
1.5.1 Global HPV Vaccines Market Size Growth Rate by Application
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global HPV Vaccines Market Size, Estimates and Forecasts
2.1.1 Global HPV Vaccines Revenue 2015-2026
2.1.2 Global HPV Vaccines Sales 2015-2026
2.2 Global HPV Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global HPV Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global HPV Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global HPV Vaccines Competitor Landscape by Players
3.1 HPV Vaccines Sales by Manufacturers
3.1.1 HPV Vaccines Sales by Manufacturers (2015-2020)
3.1.2 HPV Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 HPV Vaccines Revenue by Manufacturers
3.2.1 HPV Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 HPV Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global HPV Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by HPV Vaccines Revenue in 2019
3.2.5 Global HPV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 HPV Vaccines Price by Manufacturers
3.4 HPV Vaccines Manufacturing Base Distribution, Product Types
3.4.1 HPV Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers HPV Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into HPV Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global HPV Vaccines Market Size by Type (2015-2020)
4.1.1 Global HPV Vaccines Sales by Type (2015-2020)
4.1.2 Global HPV Vaccines Revenue by Type (2015-2020)
4.1.3 HPV Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global HPV Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global HPV Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global HPV Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 HPV Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global HPV Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global HPV Vaccines Market Size by Application (2015-2020)
5.1.1 Global HPV Vaccines Sales by Application (2015-2020)
5.1.2 Global HPV Vaccines Revenue by Application (2015-2020)
5.1.3 HPV Vaccines Price by Application (2015-2020)
5.2 HPV Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global HPV Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global HPV Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global HPV Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America HPV Vaccines by Country
6.1.1 North America HPV Vaccines Sales by Country
6.1.2 North America HPV Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America HPV Vaccines Market Facts & Figures by Type
6.3 North America HPV Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe HPV Vaccines by Country
7.1.1 Europe HPV Vaccines Sales by Country
7.1.2 Europe HPV Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe HPV Vaccines Market Facts & Figures by Type
7.3 Europe HPV Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific HPV Vaccines by Region
8.1.1 Asia Pacific HPV Vaccines Sales by Region
8.1.2 Asia Pacific HPV Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific HPV Vaccines Market Facts & Figures by Type
8.3 Asia Pacific HPV Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America HPV Vaccines by Country
9.1.1 Latin America HPV Vaccines Sales by Country
9.1.2 Latin America HPV Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America HPV Vaccines Market Facts & Figures by Type
9.3 Central & South America HPV Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa HPV Vaccines by Country
10.1.1 Middle East and Africa HPV Vaccines Sales by Country
10.1.2 Middle East and Africa HPV Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa HPV Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa HPV Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Corporation Information
11.1.2 Astellas Pharma Description and Business Overview
11.1.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma HPV Vaccines Products Offered
11.1.5 Astellas Pharma Related Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Description and Business Overview
11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL HPV Vaccines Products Offered
11.2.5 CSL Related Developments
11.3 Emergent BioSolutions
11.3.1 Emergent BioSolutions Corporation Information
11.3.2 Emergent BioSolutions Description and Business Overview
11.3.3 Emergent BioSolutions Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Emergent BioSolutions HPV Vaccines Products Offered
11.3.5 Emergent BioSolutions Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline HPV Vaccines Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description and Business Overview
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson HPV Vaccines Products Offered
11.5.5 Johnson & Johnson Related Developments
11.6 MedImmune
11.6.1 MedImmune Corporation Information
11.6.2 MedImmune Description and Business Overview
11.6.3 MedImmune Sales, Revenue and Gross Margin (2015-2020)
11.6.4 MedImmune HPV Vaccines Products Offered
11.6.5 MedImmune Related Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description and Business Overview
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck HPV Vaccines Products Offered
11.7.5 Merck Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer HPV Vaccines Products Offered
11.8.5 Pfizer Related Developments
11.9 Sanofi Pasteur
11.9.1 Sanofi Pasteur Corporation Information
11.9.2 Sanofi Pasteur Description and Business Overview
11.9.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanofi Pasteur HPV Vaccines Products Offered
11.9.5 Sanofi Pasteur Related Developments
11.10 Serum Institute
11.10.1 Serum Institute Corporation Information
11.10.2 Serum Institute Description and Business Overview
11.10.3 Serum Institute Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Serum Institute HPV Vaccines Products Offered
11.10.5 Serum Institute Related Developments
11.1 Astellas Pharma
11.1.1 Astellas Pharma Corporation Information
11.1.2 Astellas Pharma Description and Business Overview
11.1.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma HPV Vaccines Products Offered
11.1.5 Astellas Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 HPV Vaccines Market Estimates and Projections by Region
12.1.1 Global HPV Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global HPV Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America HPV Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: HPV Vaccines Sales Forecast (2021-2026)
12.2.2 North America: HPV Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: HPV Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe HPV Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: HPV Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: HPV Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: HPV Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific HPV Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: HPV Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: HPV Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: HPV Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America HPV Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: HPV Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: HPV Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: HPV Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa HPV Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: HPV Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: HPV Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: HPV Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key HPV Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 HPV Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. HPV Vaccines Market Segments
Table 2. Ranking of Global Top HPV Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global HPV Vaccines Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Adolescents
Table 5. Major Manufacturers of Adults
Table 6. Global HPV Vaccines Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global HPV Vaccines Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global HPV Vaccines Sales by Regions 2015-2020 (K MT)
Table 9. Global HPV Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global HPV Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global HPV Vaccines Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global HPV Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global HPV Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global HPV Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HPV Vaccines as of 2019)
Table 15. HPV Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. HPV Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers HPV Vaccines Price (2015-2020) (USD/MT)
Table 18. HPV Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers HPV Vaccines Product Type
Table 20. Date of International Manufacturers Enter into HPV Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global HPV Vaccines Sales by Type (2015-2020) (K MT)
Table 23. Global HPV Vaccines Sales Share by Type (2015-2020)
Table 24. Global HPV Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global HPV Vaccines Revenue Share by Type (2015-2020)
Table 26. HPV Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global HPV Vaccines Sales by Application (2015-2020) (K MT)
Table 28. Global HPV Vaccines Sales Share by Application (2015-2020)
Table 29. North America HPV Vaccines Sales by Country (2015-2020) (K MT)
Table 30. North America HPV Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America HPV Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America HPV Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America HPV Vaccines Sales by Type (2015-2020) (K MT)
Table 34. North America HPV Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America HPV Vaccines Sales by Application (2015-2020) (K MT)
Table 36. North America HPV Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe HPV Vaccines Sales by Country (2015-2020) (K MT)
Table 38. Europe HPV Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe HPV Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe HPV Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe HPV Vaccines Sales by Type (2015-2020) (K MT)
Table 42. Europe HPV Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe HPV Vaccines Sales by Application (2015-2020) (K MT)
Table 44. Europe HPV Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific HPV Vaccines Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific HPV Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific HPV Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific HPV Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific HPV Vaccines Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific HPV Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific HPV Vaccines Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific HPV Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America HPV Vaccines Sales by Country (2015-2020) (K MT)
Table 54. Latin America HPV Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa HPV Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America HPV Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America HPV Vaccines Sales by Type (2015-2020) (K MT)
Table 58. Latin America HPV Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America HPV Vaccines Sales by Application (2015-2020) (K MT)
Table 60. Latin America HPV Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa HPV Vaccines Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa HPV Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa HPV Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa HPV Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa HPV Vaccines Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa HPV Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa HPV Vaccines Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa HPV Vaccines Sales Market Share by Application (2015-2020)
Table 69. Astellas Pharma Corporation Information
Table 70. Astellas Pharma Description and Major Businesses
Table 71. Astellas Pharma HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Astellas Pharma Product
Table 73. Astellas Pharma Recent Development
Table 74. CSL Corporation Information
Table 75. CSL Description and Major Businesses
Table 76. CSL HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. CSL Product
Table 78. CSL Recent Development
Table 79. Emergent BioSolutions Corporation Information
Table 80. Emergent BioSolutions Description and Major Businesses
Table 81. Emergent BioSolutions HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Emergent BioSolutions Product
Table 83. Emergent BioSolutions Recent Development
Table 84. GlaxoSmithKline Corporation Information
Table 85. GlaxoSmithKline Description and Major Businesses
Table 86. GlaxoSmithKline HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Recent Development
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Description and Major Businesses
Table 91. Johnson & Johnson HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Recent Development
Table 94. MedImmune Corporation Information
Table 95. MedImmune Description and Major Businesses
Table 96. MedImmune HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. MedImmune Product
Table 98. MedImmune Recent Development
Table 99. Merck Corporation Information
Table 100. Merck Description and Major Businesses
Table 101. Merck HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Merck Product
Table 103. Merck Recent Development
Table 104. Pfizer Corporation Information
Table 105. Pfizer Description and Major Businesses
Table 106. Pfizer HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Pfizer Product
Table 108. Pfizer Recent Development
Table 109. Sanofi Pasteur Corporation Information
Table 110. Sanofi Pasteur Description and Major Businesses
Table 111. Sanofi Pasteur HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Sanofi Pasteur Product
Table 113. Sanofi Pasteur Recent Development
Table 114. Serum Institute Corporation Information
Table 115. Serum Institute Description and Major Businesses
Table 116. Serum Institute HPV Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Serum Institute Product
Table 118. Serum Institute Recent Development
Table 119. Global HPV Vaccines Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global HPV Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global HPV Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global HPV Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: HPV Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: HPV Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: HPV Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: HPV Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: HPV Vaccines Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: HPV Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: HPV Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: HPV Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: HPV Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: HPV Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key HPV Vaccines Players
Table 137. HPV Vaccines Customers List
Table 138. HPV Vaccines Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. HPV Vaccines Product Picture
Figure 2. Global HPV Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Adolescents Product Picture
Figure 4. Adults Product Picture
Figure 5. Global HPV Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Male
Figure 7. Female
Figure 8. HPV Vaccines Report Years Considered
Figure 9. Global HPV Vaccines Market Size 2015-2026 (US$ Million)
Figure 10. Global HPV Vaccines Sales 2015-2026 (K MT)
Figure 11. Global HPV Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global HPV Vaccines Sales Market Share by Region (2015-2020)
Figure 13. Global HPV Vaccines Sales Market Share by Region in 2019
Figure 14. Global HPV Vaccines Revenue Market Share by Region (2015-2020)
Figure 15. Global HPV Vaccines Revenue Market Share by Region in 2019
Figure 16. Global HPV Vaccines Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by HPV Vaccines Revenue in 2019
Figure 18. HPV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global HPV Vaccines Sales Market Share by Type (2015-2020)
Figure 20. Global HPV Vaccines Sales Market Share by Type in 2019
Figure 21. Global HPV Vaccines Revenue Market Share by Type (2015-2020)
Figure 22. Global HPV Vaccines Revenue Market Share by Type in 2019
Figure 23. Global HPV Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global HPV Vaccines Sales Market Share by Application (2015-2020)
Figure 25. Global HPV Vaccines Sales Market Share by Application in 2019
Figure 26. Global HPV Vaccines Revenue Market Share by Application (2015-2020)
Figure 27. Global HPV Vaccines Revenue Market Share by Application in 2019
Figure 28. North America HPV Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America HPV Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America HPV Vaccines Sales Market Share by Country in 2019
Figure 31. North America HPV Vaccines Revenue Market Share by Country in 2019
Figure 32. U.S. HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America HPV Vaccines Market Share by Type in 2019
Figure 37. North America HPV Vaccines Market Share by Application in 2019
Figure 38. Europe HPV Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe HPV Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe HPV Vaccines Sales Market Share by Country in 2019
Figure 41. Europe HPV Vaccines Revenue Market Share by Country in 2019
Figure 42. Germany HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 45. France HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe HPV Vaccines Market Share by Type in 2019
Figure 53. Europe HPV Vaccines Market Share by Application in 2019
Figure 54. Asia Pacific HPV Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific HPV Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific HPV Vaccines Sales Market Share by Region in 2019
Figure 57. Asia Pacific HPV Vaccines Revenue Market Share by Region in 2019
Figure 58. China HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 59. China HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 65. India HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific HPV Vaccines Market Share by Type in 2019
Figure 81. Asia Pacific HPV Vaccines Market Share by Application in 2019
Figure 82. Latin America HPV Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America HPV Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America HPV Vaccines Sales Market Share by Country in 2019
Figure 85. Latin America HPV Vaccines Revenue Market Share by Country in 2019
Figure 86. Mexico HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America HPV Vaccines Market Share by Type in 2019
Figure 93. Latin America HPV Vaccines Market Share by Application in 2019
Figure 94. Middle East and Africa HPV Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa HPV Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa HPV Vaccines Sales Market Share by Country in 2019
Figure 97. Middle East and Africa HPV Vaccines Revenue Market Share by Country in 2019
Figure 98. Turkey HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E HPV Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E HPV Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa HPV Vaccines Market Share by Type in 2019
Figure 105. Middle East and Africa HPV Vaccines Market Share by Application in 2019
Figure 106. North America HPV Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 107. North America HPV Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe HPV Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. Europe HPV Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific HPV Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Asia Pacific HPV Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America HPV Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Latin America HPV Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa HPV Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Middle East and Africa HPV Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- MMRワクチンの世界市場（～2026年） The MMR vaccine (also known as the MPR vaccine after the Latin names of the diseases) is an immunization vaccine against measles, mumps, and rubella (German measles). It is a mixture of live attenuated viruses of the three diseases, administered via injection. It was first developed by Maurice Hille…